Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Ibrutinib | IC50 | 0.5 [1] | |
| Ibrutinib | Ki | 4.8 [1] | |
| Fenebrutinib | IC50 | 1.4 [1] | |
| Fenebrutinib | Ki | 0.91 [1], 1.3 [2], 1.6 [3], 3.4 [4], 12.6 [5] | |
| 7-(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxoquinazolin-3-yl)phenyl]-9H-carbazole-1-carboxamide | IC50 | 26.0 [1] | |
MLA | "Quest Database™ Tyrosine-protein kinase BTK Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 7 Dec. 2025, https://www.aatbio.com/data-sets/tyrosine-protein-kinase-btk-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 7). Quest Database™ Tyrosine-protein kinase BTK Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-btk-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |